Demand for New Material Developments Impacting Non-PVC IV Bags Production, says Market.us

The industry is witnessing a rise in demand for preventive steps to avoid errors such as improper dose delivery. A rise in the demand for Non-PVC IV Bags with advanced technology has also been observed. Fagron Sterile Services US is a 503B outsourcing company that announced in March 2021 it had added intravenous bags to its product portfolio.

Problems such as drug-packaging material interactions and transporting, handling, or disposing of traditional IV containers can be caused by them. Non-PVC IV bags are able to avoid most of these problems.

Also, there is a rising demand for oncology treatments, mainly for chemotherapy and targeted drug deliveries. Most therapeutic agents are susceptible to plasticizers interaction and can become toxic agents. This discordance can be reduced if containers are not made with plasticizers.

According to Market.us. “The Global Non-PVC IV Bags Market is estimated to reach USD 5095.06 Million by 2032, up from USD 1731 Million in 2022. This market will grow at a CAGR of 11.4% over the 2023-2032 forecast period.”

These bags can be made from polypropylene, ethylene-vinyl alcohol acetate, or both. Many companies now use plasticizer-free, biocompatible material to replace polyvinyl chloride. Over the past five years, B. Braun has spent approximately USD 500.00 million to create innovative products free of PVC and DEHP.

Non-PVC IV bags can be used safely and are easy to transport. These bags are essential in operating theaters. These bags are in high demand in the oncology department. Non-PVC IV bags can be used to prevent contamination and reduce the risk of infection.

Traditional IV bags have agents like PVC that can interact with IV bags and cause unwanted substances to form. Non-PVC IV bags are not compatible with IV bags and can be easily disposed of.

Modern materials will be available in a variety of designs and the development of new materials is expected to increase the demand for non-PVC IV bags. This will also help replace glass and PVC containers.

Concerns have grown in the medical sector about PVC IV bags, which pose a risk to the environment and human health due to phthalates leaching out of equipment. It has also led to the production of toxic HCL from the incineration of PVC products.

The highest percentage for 2021 was 63.7% in single chamber segments. The current usage of single-chamber IV bags is high. As more IV containers are made with IV bags, this trend will continue. Because of their simplicity, transport, and disposal, plastic bags have replaced glass containers more quickly than ever before.

You can use intravenous solutions to treat drip bags, sterile water, irrigation fluids, and many other problems. Single-chamber bags have become more popular in recent years and will continue growing in popularity.

Market growth is also supported by the presence of local producers in the global marketplace, strict regulations regarding the disposal and use of PVC, and the development of healthcare infrastructures in emerging countries. The market for non-PVC IV bags is also driven by technological advances in service quality, and the expansion of hospitals all over the globe.

Multi-chambered segments will grow at a faster rate during the forecast. Multi-chambered IV bags may be used when intravenous treatment is necessary. Multi-Chamber IV bags made from the non-PVC film can be fast sealed and easily removed. They are often used in emergency situations.

Multi-chamber IV Bags have shorter waiting times than standard IV Bags, which is a benefit for the pharmaceutical sector. They are used extensively in pharmaceuticals because of their stability and high-pressure agility.

Multi-chambered containers, which are increasingly popular in many materials such as parenteral nutrition and drug reconstruction, have been growing in popularity. They can offer custom product options.

For liquid mixtures, the market share currently gained from non-PVC IV bags for frozen mixes is very small. PVC bags explode at low temperatures. EVA is a viable alternative to PVC’s lower temperatures. Examples of frozen mixtures are methylprednisolone and cefazolin as well as ceftriaxone and ceftriaxone hydrochloride.